Fairvalue-Calculator Fairvalue-Calculator
EN DE

ASTech Co (453860) Fair Value & Analysis

Industrials · KR · Market cap 72.9B KRW

Price10,270 KRW
Fair Value8,034 KRW
Upside-21.8%
Quality95/100
Evidence: Medium Range 6,026 KRW – 10,043 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ASTech Co (453860) currently trades at 10,270 KRW, while our model-based Fair Value estimate is 8,034 KRW — implying the stock looks roughly 21.8% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

ASTech Co., Ltd. operates as a fine chemical manufacturing company in South Korea. It offers organic UV filters, such as Uvimax Type, Uvimax DHHB, Uvimax EHT, Uvimax TDSA, and Uvimax BEMT; active pharmaceutical ingredients; and other products. The company was founded in 2005 and is headquartered in Seocheon-eup, South Korea.

Open the full interactive analysis →

Similar stocks

General Electric Company (GE) -51% RTX Corporation (RYTT34) -89% The Boeing Company (BCO) -71% Airbus SE (EADSF) -44% Safran SA (SAFRY) -39% Rolls-Royce Holdings (RYCEY) -50%

Frequently asked questions

Is ASTech Co (453860) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 8,034 KRW versus a price of 10,270 KRW — about −22% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 453860?
Our 21-model fair value for ASTech Co is 8,034 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 10,270 KRW.
What is the quality score of 453860?
ASTech Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.